PATENT CLAIM ANALYSIS

Application Number: 15762050
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-09
Patent Classification: ["424", "209100"]

Abstract:
Provided herein are optimized, recombinant influenza HA polypeptides that elicit immune responses. Also provided are compositions and kits comprising the optimized HA polypeptides as well as methods of making and using the optimized HA polypeptides.

Claim (Index 17):
The method of any one of  claims 14 - 16 , wherein the composition comprises about 1 to about 25 \u03bcg of the VLP.

Metadata:
- Claim Count in Document: 18.0
- Percentile: 90.0
- Lexical Diversity: 1.40741
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14388726', '15051991', '15392710', '14377633', '14376689']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7869365221956555
- 35 USC 102 Novelty (BERT): 0.5359180657184264
- Combined Prediction Score: 0.7618346765479326
- Mean Citation Score: 368.001672
- Max Citation Score: 375.28708
- Similarity Product: 330.43829009115694

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test